Table 3: Composition of the selected modified coconut oils (MCO1–MCO6) produced by local G. candidum through DIMOSFER process along with their antibacterial activities.

SampleSSF conditionProduct composition (%)ABA (%)
Moisture content (%)Oil content (%)Incubation time (day)MCTGMCDGMCMGMCFAE. coli S. aureus

MCO132503080151141520
MCO24210105420.522.6422.47175
MCO33001654.59.84.6531.146063
MCO43025103820.320.540.57580
MCO550251644.57.81477885
MCO6 (opt)301092416.556.45538090
Coconut oil991003.14.8
Without oil

MCO1–MCO6: modified coconut oils obtained from DIMOSFER by local G. candidum strain.
Opt: optimum condition obtained from optimization of coconut oil hydrolysis through DIMOSFER process.
Composition: MCTG: medium chain triglyceride; MCDG: medium chain diglyceride; MCMG: medium chain monoglyceride; and MCFA: medium chain fatty acid.
ABA: antibacterial activity.
Pathogenic bacteria: Escherichia coli (ATCC 10536) and Staphylococcus aureus (ATCC 25923).
Escherichia coli (1.44 × 108 CFU/mL) and Staphylococcus aureus (1.30 × 108 CFU/mL).